Sales

–

–

–

–

Royalty, license and commission income

–

–

–

–

Total revenues

–

–

–

–

Gross margin

–

–

–

–

Marketing and selling expenses

–0.4

–0.3

–0.8

–1.4

Royalty, license and commission expenses

–

–

–

–

Administration expenses

–20.6

–17.9

–40.1

–34.2

Other operating expenses and income

–4.9

18.6

–10.3

–15.5

Research and development

–

–0.1

–

–

Operating result

–24.7

2.0

–50.1

–49.5

Exceptional items

–17.3

–1.2

–17.3

–1.2

Earnings before interest and tax (EBIT)

–42.0

0.8

–67.4

–50.7

Net operating assets*

–

–

59.8

74.7

Segment liabilities*

–

–

–16.5

–14.9

Capital spending on property, plant and equipment

0.4

0.1

0.5

0.3

Investments in intangible assets

1.2

2.4

3.6

3.3

Depreciation and amortization

–1.2

–0.5

–2.6

–1.1

Impairment losses

–0.4

–

–0.4

–

Net cash flows from operating activities

–109.6

–70.1

–361.7

–181.9

Net cash flows from investing activities

–7.5

–8.8

–267.5

1,336.0

Free cash flow

–111.7

–76.2

–367.6

–196.7

Underlying free cash flow

–111.7

–72.7

–367.6

–181.3

FCR in %

–

–

–

–

ROS in %

–

–

–

–

Merck Group

€ million

Q2
2011

Q2
2010

Jan.–June
2011

Jan.–June
2010

Sales

2,469.6

2,102.8

4,947.1

4,125.6

Royalty, license and commission income

85.8

105.2

172.0

181.3

Total revenues

2,555.4

2,208.0

5,119.1

4,306.9

Gross margin

1,795.0

1,690.8

3,719.1

3,303.0

Marketing and selling expenses

–605.1

–540.2

–1,196.6

–1,008.4

Royalty, license and commission expenses

–118.5

–117.3

–229.8

–239.5

Administration expenses

–126.4

–115.2

–251.3

–219.6

Other operating expenses and income

–270.4

–109.4

–367.5

–244.4

Research and development

–369.1

–338.8

–748.6

–686.0

Operating result

–11.4

326.2

360.1

621.0

Exceptional items

–11.1

–1.2

146.9

–1.2

Earnings before interest and tax (EBIT)

–22.5

325.0

507.0

619.8

Net operating assets*

–

–

17,389.8

18,470.5

Segment liabilities*

–

–

–1,680.3

–1,898.4

Capital spending on property, plant and equipment

91.6

91.2

166.5

155.9

Investments in intangible assets

15.6

17.0

24.9

31.0

Depreciation and amortization

–308.9

–227.4

–611.4

–447.6

Impairment losses

–278.8

–7.4

–329.3

–33.6

Net cash flows from operating activities

292.2

466.2

577.1

744.9

Net cash flows from investing activities

–44.4

–112.5

59.8

1,157.0

Free cash flow

253.2

356.4

898.5

551.2

Underlying free cash flow

258.1

359.9

443.7

566.5

FCR in %

10.1

16.3

8.7

13.2

ROS in %

–0.4

14.8

7.0

14.4